Literature DB >> 34206727

Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil.

Cassia F Estofolete1,2, Cecilia A Banho1, Guilherme R F Campos1, Beatriz de C Marques1, Livia Sacchetto1, Leila S Ullmann3, Fabio S Possebon3, Luana F Machado2, Juliana D Syrio2, João P Araújo Junior3, Cintia Bittar4, Paula Rahal4, Suzana M A Lobo2, Helena Lage Ferreira5, Nikos Vasilakis6,7,8,9,10, Mauricio L Nogueira1,2.   

Abstract

The rapid development of efficacious and safe vaccines against coronavirus disease 2019 (COVID-19) has been instrumental in mitigating the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, the emergence of SARS-CoV-2 variants raised concerns on the efficacy of these vaccines. Herein, we report two cases of breakthrough infections with the P1 variant in patients vaccinated with CoronaVac, which is one of the two vaccines authorized for emergency use in the Brazilian immunization program. Our observations suggest that the vaccine reduced the severity of the disease and highlight the potential risk of illness following vaccination and subsequent infection with the P1 variant as well as for continued efforts to prevent and diagnose infection in vaccinated persons.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; vaccine

Mesh：

Substances：

Year:  2021        PMID： 34206727     DOI： 10.3390/v13071237

Source DB:  PubMed          Journal:  Viruses        ISSN： 1999-4915            Impact factor:   5.048


  23 in total

1.  Spike mutation D614G alters SARS-CoV-2 fitness.

Authors:  Jessica A Plante; Yang Liu; Jianying Liu; Hongjie Xia; Bryan A Johnson; Kumari G Lokugamage; Xianwen Zhang; Antonio E Muruato; Jing Zou; Camila R Fontes-Garfias; Divya Mirchandani; Dionna Scharton; John P Bilello; Zhiqiang Ku; Zhiqiang An; Birte Kalveram; Alexander N Freiberg; Vineet D Menachery; Xuping Xie; Kenneth S Plante; Scott C Weaver; Pei-Yong Shi
Journal:  Nature       Date:  2020-10-26       Impact factor: 49.962

2.  Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.

Authors:  Nuno R Faria; Thomas A Mellan; Charles Whittaker; Ingra M Claro; Darlan da S Candido; Swapnil Mishra; Oliver G Pybus; Seth Flaxman; Samir Bhatt; Ester C Sabino; Myuki A E Crispim; Flavia C S Sales; Iwona Hawryluk; John T McCrone; Ruben J G Hulswit; Lucas A M Franco; Mariana S Ramundo; Jaqueline G de Jesus; Pamela S Andrade; Thais M Coletti; Giulia M Ferreira; Camila A M Silva; Erika R Manuli; Rafael H M Pereira; Pedro S Peixoto; Moritz U G Kraemer; Nelson Gaburo; Cecilia da C Camilo; Henrique Hoeltgebaum; William M Souza; Esmenia C Rocha; Leandro M de Souza; Mariana C de Pinho; Leonardo J T Araujo; Frederico S V Malta; Aline B de Lima; Joice do P Silva; Danielle A G Zauli; Alessandro C de S Ferreira; Ricardo P Schnekenberg; Daniel J Laydon; Patrick G T Walker; Hannah M Schlüter; Ana L P Dos Santos; Maria S Vidal; Valentina S Del Caro; Rosinaldo M F Filho; Helem M Dos Santos; Renato S Aguiar; José L Proença-Modena; Bruce Nelson; James A Hay; Mélodie Monod; Xenia Miscouridou; Helen Coupland; Raphael Sonabend; Michaela Vollmer; Axel Gandy; Carlos A Prete; Vitor H Nascimento; Marc A Suchard; Thomas A Bowden; Sergei L K Pond; Chieh-Hsi Wu; Oliver Ratmann; Neil M Ferguson; Christopher Dye; Nick J Loman; Philippe Lemey; Andrew Rambaut; Nelson A Fraiji; Maria do P S S Carvalho
Journal:  Science       Date:  2021-04-14       Impact factor: 47.728

3.  Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.

Authors:  Rita E Chen; Xianwen Zhang; James Brett Case; Emma S Winkler; Yang Liu; Laura A VanBlargan; Jianying Liu; John M Errico; Xuping Xie; Naveenchandra Suryadevara; Pavlo Gilchuk; Seth J Zost; Stephen Tahan; Lindsay Droit; Jackson S Turner; Wooseob Kim; Aaron J Schmitz; Mahima Thapa; David Wang; Adrianus C M Boon; Rachel M Presti; Jane A O'Halloran; Alfred H J Kim; Parakkal Deepak; Dora Pinto; Daved H Fremont; James E Crowe; Davide Corti; Herbert W Virgin; Ali H Ellebedy; Pei-Yong Shi; Michael S Diamond
Journal:  Nat Med       Date:  2021-03-04       Impact factor: 87.241

4.  SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.

Authors:  Markus Hoffmann; Prerna Arora; Rüdiger Groß; Alina Seidel; Bojan F Hörnich; Alexander S Hahn; Nadine Krüger; Luise Graichen; Heike Hofmann-Winkler; Amy Kempf; Martin S Winkler; Sebastian Schulz; Hans-Martin Jäck; Bernd Jahrsdörfer; Hubert Schrezenmeier; Martin Müller; Alexander Kleger; Jan Münch; Stefan Pöhlmann
Journal:  Cell       Date:  2021-03-20       Impact factor: 41.582

5.  Have deaths from COVID-19 in Europe plateaued due to herd immunity?

Authors:  Lucy C Okell; Robert Verity; Oliver J Watson; Swapnil Mishra; Patrick Walker; Charlie Whittaker; Aris Katzourakis; Christl A Donnelly; Steven Riley; Azra C Ghani; Axel Gandy; Seth Flaxman; Neil M Ferguson; Samir Bhatt
Journal:  Lancet       Date:  2020-06-11       Impact factor: 79.321

6.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

7.  MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization.

Authors:  Kazutaka Katoh; John Rozewicki; Kazunori D Yamada
Journal:  Brief Bioinform       Date:  2019-07-19       Impact factor: 11.622

8.  A systematic review of SARS-CoV-2 vaccine candidates.

Authors:  Yetian Dong; Tong Dai; Yujun Wei; Long Zhang; Min Zheng; Fangfang Zhou
Journal:  Signal Transduct Target Ther       Date:  2020-10-13

9.  Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.

Authors:  Yanjun Zhang; Gang Zeng; Hongxing Pan; Changgui Li; Yaling Hu; Kai Chu; Weixiao Han; Zhen Chen; Rong Tang; Weidong Yin; Xin Chen; Yuansheng Hu; Xiaoyong Liu; Congbing Jiang; Jingxin Li; Minnan Yang; Yan Song; Xiangxi Wang; Qiang Gao; Fengcai Zhu
Journal:  Lancet Infect Dis       Date:  2020-11-17       Impact factor: 25.071

Review 10.  SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines.

Authors:  Paola Rogliani; Alfredo Chetta; Mario Cazzola; Luigino Calzetta
Journal:  Vaccines (Basel)       Date:  2021-03-05
View more
  10 in total

Review 1.  Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.

Authors:  Ramesh Kandimalla; Pratik Chakraborty; Jayalakshmi Vallamkondu; Anupama Chaudhary; Sonalinandini Samanta; P Hemachandra Reddy; Vincenzo De Feo; Saikat Dewanjee
Journal:  Biomedicines       Date:  2021-11-22

Review 2.  COVID-19 vaccine development: milestones, lessons and prospects.

Authors:  Maochen Li; Han Wang; Lili Tian; Zehan Pang; Qingkun Yang; Tianqi Huang; Junfen Fan; Lihua Song; Yigang Tong; Huahao Fan
Journal:  Signal Transduct Target Ther       Date:  2022-05-03

3.  Impact of SARS-CoV-2 Gamma lineage introduction and COVID-19 vaccination on the epidemiological landscape of a Brazilian city.

Authors:  Cecília Artico Banho; Lívia Sacchetto; Guilherme Rodrigues Fernandes Campos; Cíntia Bittar; Fábio Sossai Possebon; Leila Sabrina Ullmann; Beatriz de Carvalho Marques; Gislaine Ceslestino Dutra da Silva; Marília Mazzi Moraes; Maisa Carla Pereira Parra; Andreia Francesli Negri; Ana Carolina Boldrin; Michela Dias Barcelos; Thayza M I L Dos Santos; Bruno H G A Milhim; Leonardo Cecílio Rocha; Fernanda Simões Dourado; Andresa Lopes Dos Santos; Victoria Bernardi Ciconi; Caio Patuto; Alice Freitas Versiani; Rafael Alves da Silva; Edoardo Estevam de Oliveira Lobl; Victor Miranda Hernandes; Nathalia Zini; Carolina Colombelli Pacca; Cássia Fernanda Estofolete; Helena Lage Ferreira; Paula Rahal; João Pessoa Araújo; Jamie A Cohen; Cliff C Kerr; Benjamin M Althouse; Nikos Vasilakis; Mauricio Lacerda Nogueira
Journal:  Commun Med (Lond)       Date:  2022-04-13

Review 4.  Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review.

Authors:  Shilpa Gopinath; Angela Ishak; Naveen Dhawan; Sujan Poudel; Prakriti Singh Shrestha; Prabhjeet Singh; Emily Xie; Peggy Tahir; Sima Marzaban; Jack Michel; George Michel
Journal:  Trop Med Infect Dis       Date:  2022-05-22

5.  Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization.

Authors:  Marcilio Jorge Fumagalli; Luiza Antunes Castro-Jorge; Thais Fernanda de Campos Fraga-Silva; Patrick Orestes de Azevedo; Carlos Fabiano Capato; Bruna Amanda Cruz Rattis; Natália Satchiko Hojo-Souza; Vitor Gonçalves Floriano; Julia Teixeira de Castro; Simone Gusmão Ramos; Benedito Antônio Lopes da Fonseca; Vânia Luiza Deperon Bonato; Ricardo Tostes Gazzinelli; Luiz Tadeu Moraes Figueiredo
Journal:  Viruses       Date:  2021-12-04       Impact factor: 5.048

6.  Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations?

Authors:  Akshay Kanakan; Priyanka Mehta; Priti Devi; Sheeba Saifi; Aparna Swaminathan; Ranjeet Maurya; Partha Chattopadhyay; Bansidhar Tarai; Poonam Das; Vinita Jha; Sandeep Budhiraja; Rajesh Pandey
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

7.  Geographical prevalence of SARS-CoV-2 variants, August 2020 to July 2021.

Authors:  Wai Sing Chan; Yuk Man Lam; Janet Hei Yin Law; Tsun Leung Chan; Edmond Shiu Kwan Ma; Bone Siu Fai Tang
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.379

8.  Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico.

Authors:  Kame A Galán-Huerta; Samantha Flores-Treviño; Daniel Salas-Treviño; Paola Bocanegra-Ibarias; Ana M Rivas-Estilla; Eduardo Pérez-Alba; Sonia A Lozano-Sepúlveda; Daniel Arellanos-Soto; Adrián Camacho-Ortiz
Journal:  Viruses       Date:  2022-01-14       Impact factor: 5.048

9.  Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells.

Authors:  Gabriel Augusto Pires de Souza; Marion Le Bideau; Celine Boschi; Lorène Ferreira; Nathalie Wurtz; Christian Devaux; Philippe Colson; Bernard La Scola
Journal:  Viruses       Date:  2021-12-23       Impact factor: 5.048

10.  B cell receptor signatures associated with strong and poor SARS-CoV-2 vaccine responses.

Authors:  Ke Lin; Yawen Zhou; Jingwen Ai; Yan A Wang; Senxin Zhang; Chao Qiu; Chaoyang Lian; Bo Gao; Tingting Liu; Hongyu Wang; Haocheng Zhang; Yi Zhang; Zhangfan Fu; Dan Li; Ning Jiang; Jingxin Guo; Jing Wu; Yan O Wang; Shusen Song; Qiang Li; Yanan Yin; Jia Xia; Yingjie Xu; Leng-Siew Yeap; Xiaoqi Zheng; Ye Gu; Hongyan Liu; Wenhong Zhang; Fei-Long Meng
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.